Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.05%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.51 Up 0.60(6.73%) 3:59PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.14-0.13-0.60-0.28
No. of Analysts8.008.009.009.00
Low Estimate-0.20-0.20-0.82-0.54
High Estimate-0.04-0.05-0.360.13
Year Ago EPS-0.20-0.17-0.74-0.60
Revenue EstCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate13.71M15.22M59.60M99.93M
No. of Analysts7788
Low Estimate7.60M8.20M40.60M69.10M
High Estimate16.60M19.60M72.40M128.70M
Year Ago Sales14.45M16.01M54.80M59.60M
Sales Growth (year/est)-5.10%-5.00%8.80%67.70%
Earnings HistoryJun 13Sep 13Dec 13Mar 14
EPS Est-0.13-0.15-0.17-0.14
EPS Actual-0.20-0.17-0.19-0.22
Difference-0.07-0.02-0.02-0.08
Surprise %-53.80%-13.30%-11.80%-57.10%
EPS TrendsCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.14-0.13-0.60-0.28
7 Days Ago-0.14-0.13-0.60-0.28
30 Days Ago-0.13-0.12-0.58-0.23
60 Days Ago-0.13-0.12-0.57-0.18
90 Days Ago-0.12-0.10-0.45-0.15
EPS RevisionsCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0011
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstHALOIndustrySectorS&P 500
Current Qtr.30.00%N/A-63.90%12.20%
Next Qtr.23.50%N/A-63.00%20.10%
This Year18.90%11.80%100.10%8.20%
Next Year53.30%17.70%44.80%12.30%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A14.14%15.43%9.70%
Price/Earnings (avg. for comparison categories)-14.8533.736.147.61
PEG Ratio (avg. for comparison categories)N/A2.677.411.75
Currency in USD.